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Synovial fluid samples were cultured to isolate Y. entero- 
colitica on kevsinia selective agar (Oxoid, Basingstoke, 
UK) and examined with a Hyncel Counter HC-333 in 
order to determine the count of synovial leukocytes. 
Arthritis was defined as a visible joint swelling and 
evaluated by an increase in joint diameter and by 
determination of synovial exudative cell infiltration. 
The results (Table 1) showed that the acute 
phase (1-7 days postinfection) of Y entevocolitica 0:3 
experimental arthritis was related to the presence of 
bacteria within the joints. Bacteria grown at 25°C were 
detected in the joints up to the seventh day post- 
infection, and the synovial fluid response to these 
bacteria during this period showed an infiltration with 
leukocytes ranging from 3.1 x103 to 1.28x104/mL. 
In the early phase (1-3 days postinfection) the poly- 
morphonuclear leukocytes prevailed, in contrast to the 
later dominance of mononuclear cells. The incidence 
of swollen joints was greatest during the first week of 
the experiment. 
In contrast, bacteria grown at 37°C were found 
only on the first day postinfection and the experimental 
parameters (‘joint swelling and number of synovial 
exudative cells) were slightly increased. 
O f  interest was the maintenance of the chronic 
inflammatory reaction after disappearance of viable 
bacteria in both experimental groups. 
These data support the hypothesis of some authors 
[2,7] that it is not viable bacteria but some bacterial 
structures (e.g. lipopolysaccaride) that could persist in 
joints and trigger reactive arthritis. Of  special interest 
are differences in surface cell structures expressed at 
37°C and at temperatures below 30°C that affect the 
patho-genicity of Y enterocolitica 0:3. The acute arthritis 
induced by Y. enterocolitica 0:3 grown at 25°C developed 
more intensively than that induced by Y. enterocolitica 
0:3 grown at 37°C. Therefore, the experimental 
rat model of arthritis caused by Y. enterocolitica 0:3 
confirmed the importance of temperature regulation 
of yersinia pathogenic properties and their role in 
induction of reactive arthritis. 
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End-stage renal disease of the diabetic patient is an 
accepted indication for renal transplantation. To achieve 
insulin independence, a combined kidney-pancreas 
transplantation can be carried out [l]. However, the 
complication rate for this surgery is still high, par- 
ticularly with regard to infections [2-51. We conducted 
a retrospective study to analyze the postoperative 
infectious complications of the first seven combined 
kidney-pancreas grafts carried out at the Geneva 
University Hospital. 
During the surgical intervention, the kidney was 
placed in the left iliac fossa and the pancreas 
contralaterally. A duodenocystectomy drained the 
exocrine pancreatic secretion into the urinary bladder 
[6,7]. Immunosuppression therapy included cortico- 
steroids (methylprednisolone 1 mg/kg per day IV 
decreasing, then prednisone), rabbit polyclonal anti- 
lymphocyte immunoglobulins (5 mg/kg per day IV), 
azathioprine (5 mg/kg per day IV), and, from the fifth 
postoperative day, cyclosporin A (4 nig/kg per day IV). 
Rejection episodes were treated by supplementation of 
steroids, together with mono- or polyclonal antibody 
administration. In case of non-response or failure of the 
above, FK506 was utilized [8]. Ceftriaxone (2 g/day 
IV) and metronidazole (3 X 500 mg/day IV) were 
commenced intraoperatively and continued for 48 h. 
Selective digestive decontamination (SDD; polymyxin 
B (30 mg), neomycin (250 mg), vancomycin (250 mg) 
and 100 000 IU of mycostatin) of the oropharynx and 
the digestive tract was referred every 4 h, starting after 
orotracheal intubation, and was continued until 10 days 
after oral nutrition had been resumed. Prophylaxis 
against cytomegalovirus (CMV) with gancyclovir 
(2 X 5 mg/kg per day IV) for I4  days was given to 
a preoperative CMV-negative recipient and a positive 
donor. The same CMV prophylaxis was administered 
in cases of rejection. Routine microbiological surveil- 
lance cultures (respiratory secretions, blood, urine, 
abdominal drainage fluids) were performed three times 
a week; additional cultures were carried out when 
infection was clinically suspected. In cases of new, 
unexplained fever (>38.5"C), at least two blood 
cultures were drawn. Tests for viral infections, i.e. 
CMV early antigen in blood, urine or sputum were 
performed once a week. 
An infectious episode was defined as the associa- 
tion of compatible clinical signs, symptoms, laboratory 
tests and a microbiological pathogen recovered from a 
normally sterile body site and the introduction of an 
antimicrobial regimen directed against the incriminated 
microorganism. Bloodstream infection required the 
presence of clinical signs of sepsis and the isolation of 
microorganisms such as Staphylococcus aureus, Gram- 
negative bacteria or Candida species in at least one 
blood culture. For other pathogens, at least two positive 
blood cultures, or one positive blood culture associated 
with a documented primary infection site, were 
required. Pneumonia was diagnosed according to 
clinical signs and symptoms (fever, cough, dyspnea), the 
appearance of a new infiltrate on chest radiography 
and heavy growth of organisms in purulent tracheal 
secretions or bronchoalveolar lavage fluid. These samples 
were examined after Gram-staining for the detection 
and quantification of leukocytes and organisms. The 
recovery of Pneumocystis cavinii in bronchoalveolar 
lavage together with new infiltrates on chest X-ray 
defined Pneurnocystis carinii pneumonia. Diagnosis of 
peritonitis required clinical signs, the presence of 
leukocytes (> 100 white blood cells per high-power 
field) and positive cultures in peritoneal fluid obtained 
by percutaneous puncture or during surgery. An abscess 
was defined as a localized collection of purulent fluid, 
with typical clinical findings and positive micro- 
biological cultures, confirmed by computerized tomo- 
graphy or laparotomy. The diagnosis of urinary tract 
infection required the isolation of at least 10' micro- 
organisms/mL once, or 105 yeast/mL on two occasions, 
associated with at  least two of the following: dysuria; 
pollakiuria; and/or pyuria (10 white blood cells per 
high-power field). A wound infection was defined as 
an infection occurring at an incision site within 30 days 
after surgery involving the skin, subcutaneous tissue, or 
muscle located above fascia1 layer. The diagnosis of 
fungal infection was based on either: (1) positive blood 
culture, or (3) isolation of fungi from an abdominal 
sample with evidence of peritonitis or an abdominal 
abscess. CMV infection was confirmed by sero- 
conversion of CMV-specific IgG and IgM in a pre- 
viously sero-negative patient (primary infection), or by 
detection of a significant rise (more than four dilutions) 
in CMV IgG antibodies with or without detectable 
CMV IgM antibodies (secondary infection or 
reactivation). Leuko-cytes from peripheral blood 
cocultured with human embryogenic lung fibroblasts 
for 6 weeks and showing a cytopathogenic effect 
confirmed CMV infection in some cases. CMV disease 
was diagnosed when CMV infection was temporally 
associated with: (1) gastro-enteritis-upper or lower 
gastrointestinal symptoms with CMV detected in 
biopsy material from the gastrointestinal tract; (2) 
hepatitis-abnormal liver function tests in the absence 
of bacterial or fungal infection and/or transplant 
rejection, with CMV detected on liver biopsy by 
virologic and/or histologic techniques; (3) pneu- 
monitis-pulmonary chest symp-toms and/or a typical 
chest radiographic pattern, lack of clinical response to 
antibiotics and evidence of CMV in bronchoalveolar 
lavage fluids. 
5 0  C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  Vo lume 5 Number  1, J a n u a r y  1999 
Table 1 Postoperative infectious episodes per patient and infection site 
Patient no. Days after TX Site Bacteria/Fungus/Virus 
1 
2 
3 
4 
5 
10 
46 
176 
6 
21 
28 
49 
9 
34 
59 
20 
38 
11 
97 
Urine Klebsiella pneumoniae 
Urine K .  pneumoniae 
Urine and abdomen Torulopsis glabrata 
Urine 
Urine 
Urine 
Urine 
Abdomen 
Abdomen 
Urine 
Urine 
Urine 
Blood 
Urine 
Caudida albicans 
C. albicans 
K. pneumoniae 
C. albicans 
Staphylococcus epidermidis 
S. epidermidis + C. albicans 
C. albicans 
Enterococcus 
Enterococcus + S. epidermidis 
CMV 
Pseudomonas aeruginosa + S. epidermidis + CMV 
6 No infection 
7 a  8 Abdomen S. epidermidis + C .  albicans 
8 Blood C. albicans 
C. albicans 35 Blood 
’died; Tx, transplantation. 
The seven patients spent a total of 559 days in 
hospital, i.e. 170 days in the surgical intensive care unit 
and 389 in the visceral surgery clinic. One  patient 
died of infection on the 69th post-transplant day. The 
bacteriologic sampling consisted of 887 bacteriologic 
specimens, including 346 blood cultures. There were 
17 infectious episodes, 13 caused by one micro- 
organism and four polymicrobial (Table 1). Only one 
patient had no infectious episodes. Only three infection 
sites were involved. The urinary tract was the most 
often infected site, followed by the peritoneal cavity 
and the blood. 
Fungal infections were responsible for 41% of all 
infectious episodes, and Candida spp. were responsible 
for 89% of these. Two episodes of arterial mycotic 
aneurysm at the site of the arterial anastomosis used to 
rearterialize the homograft were diagnosed. Thirty-five 
per cent of all infectious episodes were caused by 
bacteria, and coagulase-negative staphylococci were the 
most frequent bacteria isolated. Both bacteria and fungi 
or bacteria and CMV grew in 12% and 6% of the 
cultures, respectively. CMV (6% of all infections) was 
isolated twice in the blood and once in the urine, at 
different periods in the same patient. One  case of 
protozoal infection (toxoplasmosis) was diagnosed post 
mortem. 
Using predefined infection definitions, our retro- 
spective analysis of kidney-pancreatic transplantation 
shows that six of seven patients developed one or more 
severe infections, all of them originating from either the 
urinary tract or the peritoneal cavity. Studies on similar 
patient populations showed an infection rate between 
56% and 90% of the patients with predominant urinary 
tract infection (mean 76%) [3,9-151. An interesting 
element is that fungal infections developed in more 
than 25% of the transplanted patients, and this infection 
rate is not altered by either SDD with antifungal 
prophylaxis or systemic administration of antifungal 
therapy [2,5,16-191. This tendency is confirmed by 
Sollinger, who described a large series of kidney- 
pancreas transplants and concluded that ‘fungal in- 
fection occurs with significant frequency despite 
aggressive antifungal therapy and prophylaxis’ [20]. The 
prevalence of urinary tract infections is not surprising 
and many factors may contribute. For example, sur- 
gically induced mucosal trauma and sutures, pancreatic 
exocrine secretions in the bladder, which raise the 
urine p H  and may induce an inflammatory reaction, 
and the prolonged use of bladder catheter, are factors 
contributing to bacterial growth [21]. Such a high 
infection rate when exocrine pancreatic bladder drainage 
is used has stimulated renewed interest in enteric 
drainage [22,23] and has encouraged the development 
of alternative techniques such as the transplantation of 
Langerhans islets [24]. 
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